Table 1 Main baseline clinical and biochemical characteristics of the study population
Baseline values | Difference between arms at baseline (P-value) | |
|---|---|---|
Age (years) | 57 (48, 63) | 0.01 |
Weight (kg) | 65 (62, 78) | 0.43 |
BMI (kg/m2) | 24 (21, 27) | 0.89 |
WC (cm) | 88 (84, 94) | 0.91 |
BIA (%) | 31 (27, 40) | 0.99 |
VFR (%) | 11 (8, 12) | 0.91 |
SBP (mmHg) | 120 (120, 130) | 0.54 |
DBP (mmHg) | 80 (80, 80) | 0.88 |
HR (bpm) | 64 (60, 68) | 0.24 |
TC (mg/mL) | 271 (247, 288) | 0.51 |
LDL-C (mg/mL) | 180 (170, 196) | 0.29 |
HDL-C (mg/mL) | 60 (43, 77) | 0.51 |
Non-HDL-C (mg/mL) | 210 (193, 228) | 0.24 |
TG (mg/mL) | 115 (94, 150) | 0.79 |
apoAI (mg/dL) | 118 (95, 133) | 0.28 |
apoB (mg/dL) | 146 (134, 155) | 0.07 |
oxLDL (U/L) | 76.6 (69.7, 86.7) | 0.08 |
Lp(a) (mg/dL) | 6 (4, 12) | 0.32 |
PCSK9 (ng/dL) | 341 (285, 403) | 0.81 |
FPG (mg/dL) | 95 (89, 98) | 0.97 |
Insulin (mUI/L) | 3.38 (2.46, 4.92) | 0.64 |
HOMA-IR | 0.75 (0.57, 1.15) | 0.72 |
FGF19 (pg/mL) | 227 (173, 337) | 0.87 |
FGF21 (pg/mL) | 179 (119, 229) | 0.37 |